Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 6Thoracic 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 3Non Small Cell Lung Carcinoma NSCLC 2Neoplasm Metastasis 2NSCLC 2Unresectable Stage III NSCLC 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Non-Small Cell Lung Cancer With HER2- Mutations 1Neoplasms 1First-line Advanced NSCLC Patients 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Pancreatic Ductal 1Carcinoma 1

Interventions

pembrolizumab 7Carboplatin 5Cisplatin 4Drug Therapy 3Taxes 2Specimen Handling 2SS1(dsFv)PE38 2Polymerase Chain Reaction 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Fluorouracil 2Doxorubicin 2Cyclophosphamide 2130-nm albumin-bound paclitaxel 2tremelimumab 1tocilizumab 1tinostamustine 1sodium thiosulfate 1selinexor 1rucaparib 1olaparib 1motexafin lutetium 1liposomal doxorubicin 1fludarabine 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × CP protocol × Thoracic × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡